With the number of cancer survivors growing, the medical profession needs to start paying more attention to how to keep these people healthy throughout their now-extended lifetimes, said senior researcher Dr. Shahrukh Hashmi. He is an assistant professor of medicine at the Mayo Clinic in Rochester, Minn. "We are now beginning to see the gravity of a multitude of complications among cancer survivors," Hashmi said. "There is an essential and immediate need for formal cancer survivorship programs to prevent complications in millions of cancer survivors." Currently there are about 30 million cancer survivors worldwide, but researchers predict that about 19 million new cancer diagnoses will be made every year by 2025. Many of those people will survive their cancer, only to face long-term health consequences.
Reach: US News reaches more than 10 million unique visitors to its website each month.
Context: Shahrukh Hashmi, M.D. is a Mayo Clinic Public Health and General Preventive Medicine Specialist. Dr. Hashmi studies cancer survivorship and late effects of blood and marrow transplantation. This includes physical and psychosocial illnesses that result as a late effect of chemotherapy or radiation. The translational aspect of Dr. Hashmi's research focuses on the biology of aging in cancer survivors. Dr. Hashmi's interests also include development of novel agents for treatment of graft-versus-host disease.
Contact: Joe Dangor